← Back to all trials
Recruiting
NCT05670418
Cognitive Function Analysis and qEEG Study in Long COVID-19 Syndrome Patients
Conditions: Long COVID-19 Syndrome
Sex: All
Ages: 18 Years – N/A
Enrollment: 45
Sponsor: Indonesia University
Location: Indonesia
Summary
Over than 30% individuals with COVID-19, including the asymptomatic ones, and around 80% of patients hospitalized with COVID-19 may experience post-COVID sequelae, which is commonly referred to as Long COVID Syndrome.
This condition has ties to decreased cognitive function and may lead to neuropsychiatric disorders but still need to be studied further.
Using a cross-sectional design, this study will analyze the relationship between cognitive function and neuropsychiatric disorders with brain wave activity in Long COVID patients.The investigators conducted assessments utilizing the quantitative electroencephalogram (qEEG) measurement method and interviews using instruments such as the MMSE MOCA, mini ICD 10, and SF 36.
With this qEEG examination, the investigators hoped that there will be an imbalance/abnormality of brain wave activity that arises related to impaired cognitive function.
Eligibility Criteria
Inclusion Criteria:Post-COVID-19 patients with Long COVID-19 SyndromeOver 18 years oldWilling to participate in the researchCompleted the MMSE MOCA, MINI ICD-10, and SF-36 assessmentExclusion Criteria:1. Patients with neuropsychiatric disorders before being infected with COVID-19
Source: ClinicalTrials.gov (NCT05670418). StuddyBuddy aggregates publicly available trial information.